Scientist Solutions: International Life Science Community By Scientists For Scientists
    
Home » Protocols » The JAM-assay: optimized conditions to determine death-receptor-mediated apoptosis
Thanks to our sponsors who make this site possible
Protocol for

The JAM-assay: optimized conditions to determine death-receptor-mediated apoptosis

Would you like to save this topic, event, protocol or job so you can find it again easily?

Just click the "Save to My Lab Drawer" link and the item will be saved in the My Lab Drawer section of your bench space.

Available to members only. Please log in or register for your free account now.

Abstract or Description:

Apoptosis induced by interaction of members of the TNF-/TNF-receptor superfamily has been considered as a major mechanism of cell-mediated cytotoxicity. For functional analysis, the 51Cr release assay has been widely used, which requires loss of membrane integrity in the apoptotic target cell. However, loss of membrane integrity is a late event during apoptosis and therefore only late apoptotic cells will be detected by this method. In contrast, the JAM-assay first described by Polly Matzinger has been demonstrated to be more sensitive than the 51Cr release assay, since this method is dependent on DNA-fragmentation which precedes loss of membrane integrity in most apoptotic cells. The JAM-assay is easier to perform, less expansive, and safer than the current standard 51Cr release assay. Therefore, this article will focus on optimized conditions of the JAM-assay to detect and quantitate Fas (CD95/Apo-1)-induced apoptosis as an example of death-receptor-mediated cytotoxicity.

Citation: http://dx.doi.org/10.1016/S1046-2023(03)00122-1
Attachments: No Attachments
Posted By: ProtocolFinder on 4/9/2009 6:00:35 PM
Comments
Add Comment